SCOPUS 정보 검색 플랫폼

Neurology

Volumn 55, Issue 12 SUPPL. 5, 2000, Pages

Use of botulinum toxin type A in the treatment of cervical dystonia

(3) Comella, C L a Jankovic, J a Brin, M F a

a RUSH UNIVERSITY MEDICAL CENTER (United States)

Author keywords

Botulinum toxin; Immunoresistance; Spasmodic torticollis

Indexed keywords

BOTULINUM TOXIN A;

ACETYLCHOLINE RELEASE; CHOLINERGIC SYNAPSE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; DYSPHAGIA; DYSPHONIA; DYSTONIA; HUMAN; LETHARGY; MUSCLE CONTRACTION; MUSCLE WEAKNESS; NECK PAIN; NEUROMUSCULAR SYNAPSE; PRIORITY JOURNAL; SPASMODIC TORTICOLLIS; XEROSTOMIA;

DYSTONIA; HUMANS; NECK MUSCLES;

EID: 0034719036 PISSN: 00283878 EISSN: None Source Type: Journal
DOI: None Document Type: Conference Paper

Times cited : (73)

References (56)

1
- 0024469216
- Comparison of the effects of botulinum toxin in adult and neonatal rats: Neuromuscular blockade and toxicity
- (1989) Can J Physiol Pharmacol , vol.67 , pp. 879-882
- Bambrick, L.L.¹ Gordon, T.²

2
- 0025706199
- Botulinum toxin
- (1990) NIH Consensus Statement , vol.8 , pp. 1-20

3
- 0019761968
- Botulinum toxin injection of eye muscles to correct strabismus
- (1981) Trans Am Ophthalmol Soc , vol.79 , pp. 734-770
- Scott, A.B.¹

4
- 0004260768
- New York: Marcel Dekker
- (1994) Therapy with botulinum toxin , pp. 1-608
- Jankovic, J.¹ Hallett, M.²

5
- 0000810225
- Botulinum toxin: Historical perspective and potential new indications
- (1997) Muscle Nerve , vol.20 , Issue.SUPPL. 6
- Jankovic, J.¹ Brin, M.²

6
- 0034105251
- Botulinum toxin therapy
- (2000) Neurologist , vol.6 , pp. 98-115
- Gracies, J.-M.¹ Simpson, D.M.²

7
- 0019161371
- Clostridium botulinum neurotoxin
- (1980) Microbiol Rev , vol.44 , pp. 419-448
- Sugiyama, H.¹

8
- 0022587865
- Double-blind study of botulinum toxin in spasmodic torticollis
- (1986) Lancet , vol.2 , pp. 245-247
- Tsui, J.K.C.¹ Eisen, A.² Stoessl, A.J.³ Calne, S.⁴ Calne, D.B.⁵

9
- 0023142826
- Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study
- (1987) Neurology , vol.37 , pp. 616-623
- Jankovic, J.¹ Orman, J.²

10
- 4243364810
- Botulinum toxin treatment of movement disorders
- Gilman S, Goldstein GW, Waxman SG, eds. Neurobase. 3rd ed. San Diego: Arbor Publishing
- (1999)
- Adler, C.H.¹

11
- 0001854415
- Controlled trials of botulinum toxin for cervical dystonia: A critical review
- Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker
- (1994) , pp. 279-287
- Greene, P.¹

12
- 0006246613
- New York: Churchill Livingstone
- (1994) Handbook of botulinum toxin treatment for cervical dystonia
- Jankovic, J.¹ Brin, M.F.² Comella, C.³

13
- 0004265462
- Oxford: Butterworth-Heinemann
- (1994) Movement disorders 3
- Masden, C.D.¹ Fahn, S.²

14
- 0001950143
- Experience with botulinum toxin in cervical dystonia
- Jankovic J, Hallet J, eds. Therapy with botulinum toxin. New York: Marcel Dekker
- (1994) , pp. 267-278
- Poewe, W.¹ Wissel, J.²

15
- 0029956621
- Botulin toxin as a therapeutic agent
- (1996) Pharmacol Ther , vol.72 , pp. 13-24
- Tsui, J.K.C.¹

16
- 0031609926
- Medical therapy and botulinum toxin in dystonia
- Fahn S, Marsden CD, DeLong M, eds. Dystonia 3: advances in neurology. Philadelphia: Lippincott-Raven Publishers
- (1998) , pp. 169-183
- Jankovic, J.¹

17
- 0034651211
- Uses of botulin toxin injection in medicine today
- (2000) BMJ , vol.320 , pp. 161-165
- Müchau, A.¹ Bhatia, K.P.²

18
- 0025766742
- Electromyographic guidance of botulinum toxin treatment in cervical dystonia
- (1991) Clin Neuropharmacol , vol.14 , pp. 262-267
- Dubinsky, R.M.¹ Gray, C.S.² Vetere-Overfield, B.³ Koller, W.C.⁴

19
- 0026609579
- Botulinum toxin injection for spasmodic torticollis: Increased magnitude of benefit with electromyographic assistance
- (1992) Neurology , vol.42 , pp. 878-882
- Comella, C.L.¹ Buchman, A.S.² Tanner, C.M.³ Brown-Toms, N.C.⁴ Goetz, C.G.⁵

20
- 0029050280
- Botulinum toxin in cervical dystonia: Low dosage with electromyographic guidance
- (1995) J Neurol , vol.242 , pp. 529-534
- Brans, J.W.¹ De Boer, I.P.² Aramideh, M.³ Ongerboer de Visser, B.W.⁴ Speelman, J.D.⁵

21
- 0029297916
- Cervical dystonia: A review of the role of botulinum toxin
- (1995) Nebr Med J , vol.80 , pp. 109-115
- Edwards, L.L.¹ Normand, M.M.² Wszolek, Z.K.³

22
- 0027582697
- Use of botulinum toxin in the treatment of cervical dystonia
- (1993) Baillieres Clin Neurol , vol.2 , pp. 179-185
- Poewe, W.¹ Wissel, J.²

23
- 0029041999
- Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin
- (1995) Muscle Nerve , vol.18 , pp. 720-729
- Van den Bergh, P.¹ Francart, J.² Mourin, S.³ Kollmann, P.⁴ Laterre, E.C.⁵

24
- 6844266275
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group
- (1998) J Neurol Neurosurg Psychiatry , vol.64 , pp. 13-17
- Poewe, W.¹ Deuschl, G.² Nebe, A.³ et, al..⁴

25
- 0033957251
- Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study
- (2000) Eur Neurol , vol.43 , pp. 9-12
- Rollnik, J.D.¹ Matzke, M.² Wohlfarth, K.³ Dengler, R.⁴ Bigalke⁵

26
- 0028345811
- Development of resistance to botulinum toxin type A in patients with torticollis
- (1994) Mov Disord , vol.9 , pp. 213-217
- Greene, P.¹ Fahn, S.² Diamond, B.³

27
- 0029977787
- Botulinum toxin therapy, immunologic resistance, and problems with available materials
- (1996) Neurology , vol.46 , pp. 26-29
- Borodic, G.¹ Johnson, E.² Goodnough, M.³ Schantz, E.⁴

28
- 0025305554
- Botulinum toxin injections for cervical dystonia
- (1990) Neurology , vol.40 , pp. 277-280
- Jankovic, J.¹ Schwartz, K.²

29
- 0026808303
- Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients
- (1992) J Neurol , vol.239 , pp. 21-25
- Poewe, W.¹ Schelosky, L.² Kleedorfer, B.³ Heinen, F.⁴ Wagner, M.⁵ Deuschl, G.⁶

30
- 0029030965
- Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia
- (1995) J Formos Med Assoc , vol.94 , pp. 189-192
- Lu, C.S.¹ Chen, R.S.² Tsai, C.H.³

31
- 0026355774
- Clinical correlates of response to botulinum toxin injections
- (1991) Arch Neurol , vol.48 , pp. 1253-1256
- Jankovic, J.¹ Schwartz, K.S.²

32
- 0028151591
- Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study
- (1994) Electroencephalogr Clin Neurophysiol , vol.93 , pp. 434-439
- Ostergaard, L.¹ Fuglsang-Frederiksen, A.² Werdelin, L.³ Sjo, O.⁴ Winkel, H.⁵

33
- 9244220100
- Botulinum toxin versus trihexyphenidyl in cervical dystonia: A prospective, randomized, double-blind controlled trial
- (1996) Neurology , vol.46 , pp. 1066-1072
- Brans, J.W.¹ Lindeboom, R.² Snoek, J.W.³ et, al..⁴

34
- 0027276523
- Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia
- (1993) Clin Neuropharmacol , vol.16 , pp. 205-210
- Buchman, A.S.¹ Comella, C.L.² Stebbins, G.T.³ Tanner, C.M.⁴ Goetz, C.G.⁵

35
- 4243627675
- Drug treatment of dystonia
- Quinn NP, Jenner PG, eds. Disorders of movement. San Diego: Academic Press
- (1989) , pp. 313-321
- Lang, A.E.¹

36
- 0020404121
- Tardive dystonia: Late-onset and persistent dystonia caused by antipsychotic drugs
- (1982) Neurology , vol.32 , pp. 1335-1346
- Burke, R.E.¹ Fahn, S.² Jankovic, J.³ et, al..⁴

37
- 0031985415
- Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A
- (1998) Mov Disord , vol.13 , pp. 158-161
- Brashear, A.¹ Ambrosius, W.T.² Eckert, G.J.³ Siemers, E.R.⁴

38
- 0031026930
- An open-label study of botulinum toxin A for treatment of tardive dystonia
- (1997) Clin Neuropharmacol , vol.20 , pp. 90-93
- Tarsy, D.¹ Kaufman, D.² Sethi, K.D.³ Rivner, M.H.⁴ Molho, E.⁵ Factor, S.⁶

39
- 0000206912
- Non-responders
- Abstract
- (1995) Mov Disord , vol.10 , pp. 392
- Critchley, E.M.R.¹ Rajamani, K.² Savant, C.³

40
- 0031239673
- Botulinum A toxin therapy: Neutralizing and nonneutralizing antibodies-therapeutic consequences
- (1997) Exp Neurol , vol.147 , pp. 96-102
- Göschel, H.¹ Wohlfarth, K.² Frevert, J.³ Dengler, R.⁴ Bigalke, H.⁵

41
- 0033023671
- Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins
- (1999) Crit Rev Immunol , vol.19 , pp. 219-260
- Atassi, M.Z.¹ Oshima, M.²

42
- 0031776446
- Mouse bioassay versus Western blot assay for botulinum toxin antibodies: Correlation with clinical response
- (1998) Neurology , vol.50 , pp. 1624-1629
- Hanna, P.A.¹ Jankovic, J.²

43
- 0032892281
- Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies
- (1999) J Neurol Neurosurg Psychiatry , vol.66 , pp. 612-616
- Hanna, P.A.¹ Jankovic, J.² Vincent, A.³

44
- 0027421580
- Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance
- (1993) Neurology , vol.43 , pp. 1715-1718
- Zuber, M.¹ Sebald, M.² Bathien, N.³ De Recondo, J.⁴ Rondot, P.⁵

45
- 0031984577
- Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections
- (1998) Mov Disord , vol.13 , pp. 150-154
- Sankhla, C.¹ Jankovic, J.² Duane, D.³

46
- 0023798433
- Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralizing test and by an enzyme-linked immunoabsorbent assay
- (1988) J Clin Microbiol , vol.26 , pp. 2351-2356
- Siegel, L.S.¹

47
- 0002267607
- Immunogenicity of the neurotoxins of Clostridium botulinum
- Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker
- (1994) , pp. 93-108
- Hatheway, C.L.¹ Dang, C.²

48
- 0031596997
- A radioimmunoprecipitation assay for antibodies to botulinum A
- (1998) Neurology , vol.50 , pp. 1463-1466
- Palace, J.¹ Nairne, A.² Hyman, N.³ et, al..⁴

49
- 0027136044
- Serum antibody production to botulinum A toxin
- (1993) Ophthalmology , vol.100 , pp. 1861-1866
- Siatkowski, R.M.¹ Tyutyunikov, A.² Biglan, A.W.³ et, al..⁴

50
- 0002923670
- Assays for botulinum and tetanus toxins
- Simpson LL, ed. Botulinum neurotoxin and tetanus toxin. San Diego: Academic Press
- (1989) , pp. 319-331
- Notermans, S.¹ Nagel, J.²

51
- 0021869121
- Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay
- (1985) Appl Environ Microbiol , vol.50 , pp. 63-67
- Shone, C.¹ Wilton-Smith, P.² Appleton, N.³ et, al..⁴

52
- 0032239987
- Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin
- (1998) J Neurol Neurosurg Psychiatry , vol.65 , pp. 924-927
- Naumann, M.¹ Toyka, K.V.² Mansouri Taleghani, B.³ Ahmadpour, J.⁴ Reiners, K.⁵ Bigalke, H.⁶

53
- 0022313043
- Reversible esophageal motor dysfunction in botulism
- (1985) Muscle Nerve , vol.8 , pp. 791-795
- Nix, W.A.¹ Eckardt, V.F.² Kramer, G.³

54
- 0027976367
- Histologic assessment of dose related diffusion and muscle fiber response after therapeutic botulinum toxin A injections
- (1994) Mov Disord , vol.9 , pp. 31-39
- Borodic, G.E.¹ Ferrante, R.² Pearce, L.B.³ Smith, K.⁴

55
- 0026544139
- Botulinum A toxin for spasmodic torticollis: Multiple vs. single injection points per muscle
- (1992) Head Neck , vol.14 , pp. 33-37
- Borodic, G.E.¹ Pearce, L.B.² Smith, K.³ Joseph, M.⁴

56
- 0028027689
- Training guidelines for the use of botulinum toxin for the treatment of neurological disorders
- (1994) Neurology , vol.44 , pp. 2401-2403

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.